Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 30, 2024DiabetologiaOpen Access

Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial

View Full Paper
Ask AI
Bookmark
Share

Authors

LVLiv VernstrømAarhus UniversitySGSøren GullaksenAarhus UniversitySSSteffen S. SørensenAarhus University Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vernstrøm et al. (2024) studied this question.

synapsesocial.com/papers/68e5e7feb6db64358757c47ahttps://doi.org/10.1007/s00125-024-06228-y
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials2021 · 691 citations
  2. 2Renal and renal sinus fat volumes as quantified by magnetic resonance imaging in subjects with prediabetes, diabetes, and normal glucose tolerance2020 · 70 citations
  3. 3Kidney Disease and Increased Mortality Risk in Type 2 Diabetes2013 · 1,310 citations
  4. 4New Magnetic Resonance Imaging Index for Renal Fibrosis Assessment: A Comparison between Diffusion-Weighted Imaging and T1 Mapping with Histological Validation2016 · 151 citations
  5. 5Renal fibrosis detected by diffusion-weighted magnetic resonance imaging remains unchanged despite treatment in subjects with renovascular disease2020 · 19 citations